NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Health Information Services · USD

Schrödinger, Inc. (SDGR) Stock Analysis

Schrödinger, Inc. (SDGR) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

SDGR

$23.90

+$0.50 (+2.14%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SDGR with… →

SDGR Key Statistics

As of Oct 21, 2026
Trading
Open
$23.67
Previous Close
$23.40
Day's Range
23.24–24.26
52-Week Range
10.95–33.78
Volume
1.06M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.62
Valuation
Market Cap
$1.79B
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
6.90
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.74
Financials (FY)
Revenue (FY)
$255.87M+23.29%
Net Income (FY)
−$103.27M
Profit marginThe share of revenue left as profit after all costs and taxes.
−20.98%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
65.64M
1-Year Return
+14.52%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
1.89M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, SDGR closed at $23.90, +14.52% over 1 year.

Schrödinger, Inc. (SDGR) has a market capitalization of $1.79B.

In fiscal 2025, SDGR reported revenue of $255.87M.

SDGR Stock Return by Calendar Year

Schrödinger, Inc. (SDGR) return since Feb 2020: what $10,000 became

1 year
$10,000 $11,452
+14.52%
5 years
$10,000 $4,268
−57.32%
Since Feb 2020
$10,000 $8,345
−16.55%

If you had invested $10,000 in Schrödinger, Inc. (SDGR) at the close on February 6, 2020, the earliest close on record here, it would have been worth $8,345 at the close on October 21, 2026: −16.55% in total, −2.66% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+33.67%
2025−7.31%
2024−46.12%
2023+91.55%
2022−46.34%
2021−56.01%
2020 (partial year)+176.47%

As of October 21, 2026.

SDGR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$255.87M−$103.27M−40.4%
2024$207.54M−$187.12M−90.2%
2023$216.67M$40.72M18.8%
2022$180.96M−$149.19M−82.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$255.87M$142.61M−$166.90M−$103.27M−40.4%
2024$207.54M$132.08M−$209.30M−$187.12M−90.2%
2023$216.67M$140.69M−$177.45M$40.72M18.8%
2022$180.96M$101.02M−$146.82M−$149.19M−82.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SDGR Valuation vs Health Information Services Median

Median of 44 stocks
MetricSDGRHealth Information Services medianvs median
P/S ratio6.902.31199% above
Profit margin−20.98%−7.55%13.4 pts below

Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Schrödinger, Inc. (SDGR) is capitalised at $1.79B on the latest close. The company sits in the Healthcare sector, in the Health Information Services industry. Headcount on file is 850.

The 52-week range on file runs from $10.95 to $33.78. The most recent close on file for SDGR is $23.90, dated October 21, 2026. That is +$0.50 (+2.14%) against the previous close. The latest close sits 118.36% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $255.87M. Against the prior fiscal year total of $207.54M, that is a change of +23.29%. The same year closed with a net loss of $103.27M. The reported profit margin is −20.98%. That is 13.4 percentage points below the Health Information Services median of −7.55%. Earnings per share on a trailing basis come to −0.74.

Across the 4 fiscal years on file, revenue moves from $180.96M in 2022 to $255.87M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 6.9. On price-to-sales that is 199.27% above the Health Information Services median of 2.31. 44 Health Information Services companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is +14.52%. Measured over 5 years, that is −15.66% a year compounded. The reported beta is 1.62. Daily returns over the trailing 6 years annualize to a volatility of 65.27%.

Growth & Income

The record shows no dividend for SDGR.

2026 is still running; the total return is +33.67% year to date. The strongest complete calendar year on file is 2023 at +91.55%; the weakest is 2021 at −56.01%. Of the 5 complete calendar years on file, 1 finished higher.

Peer Comparison

Schrödinger, Inc. (SDGR) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Schrödinger, Inc. SDGR $1.79B —
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. Schrödinger, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$51.90B

 BTSG

BrightSpring Health Services, Inc.

$12.40B

 TEM

Tempus AI, Inc.

$12.23B

 HNGE

Hinge Health, Inc.

$9.04B

 HQY

HealthEquity, Inc.

$8.10B

 DOCS

Doximity, Inc.

$5.99B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Visit website →